Graves' ophthalmopathy: The case for thyroid surgery

Surgeon

Volumn 7, Issue 5, 2009, Pages 290-296

  Lowery, A J ^a   Kerin, M J ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Graves' disease; ophthalmopathy; subtotal thyroidectomy; thyroid; total thyroidectomy

Indexed keywords

ARTICLE; ENDOCRINE OPHTHALMOPATHY; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; THYROIDECTOMY;

GRAVES OPHTHALMOPATHY; HUMANS; THYROIDECTOMY;

EID: 71049130375     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(09)80007-3     Document Type: Article

References (79)

1. Graves R.J. New observed affection of the thyroid gland in females. (Clinical lectures) London Medical and Surgical Journal (Renshaw) 7 (1835) 516-517
2. Sawin C. Theories of causation of Graves' disease. A historical perspective. Endocrin Metab Clin North Am 27 63 (1998)
3. Von Basedow K.A. Exophthalmus durch Hypertrophie des Zellgewebes in der Augenhöhle. Wochenschrift für die gesammte Heilkunde, Berlin 6 (1840) 197-204
4. Weetman A.P. Graves' disease. N Engl J Med 343 17 (2000 Oct 26) 1236-1248
5. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med 199;329(20)1468-75
6. Villadolid M.C., Yokoyama N., Izumi M., et al. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. J Clin Endocrinol Metab 80 9 (1995) 2830-2833
7. El-Kaissi S., Frauman A.G., and Wall J.R. Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Intern Med J 34 8 (2004) 482-491
8. Yamada M., Li A.W., and Wall J.R. Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management. Crit Rev Clin Lab Sci 37 6 (2000) 523-549
9. Mclver B., and Morris J.C. The pathogenesis of Graves' disease. Endocrinol Metab Clin North Am 27 1 (1998) 73-89
10. Di Paulo R.M.C., De Filippis D., Corda, et al. Cyclo-oxygenase dependent thyroid cell proliferation induced by immunoglobulins in patients with Graves' disease. J Clin Endocrinol Metab 82 (1997) 670-673
11. Bahn R.S. Cytokines in thyroid eye disease: potential for anticytokine therapy. Thyroid 8 5 (1998) 415-418
12. Kendall-Taylor P., Knox A.J., Steel N.R., et al. Evidence that thyroid-stimulating antibody is produced in the thyroid gland. Lancet 1 8378 (1984) 654-656
13. Feliciello A., Porcellini A., Ciullo I., et al. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342 8867 (1993) 337-338
14. Bahn R.S., Dutton C.M., Joba W., et al. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotro-pin. Thyroid 8 2 (1998) 193-196
15. Bahn R.S., Dutton C.M., Natt N., et al. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthal-mopathy. J Clin Endocrinol Metab 83 3 (1998) 998-1002
16. McGregor A.M. Has the target autoantigen for Graves' ophthalmopathy been found?. Lancet 352 9128 (1998) 595-596
17. Pappa A., Calder V., Ajjan R., et al. Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol 109 2 (1997) 362-369
18. Pappa A., Lawson J.M., Calder V., et al. T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy. Br J Ophthalmol 84 5 (2000) 517-522
19. Otto E.A., Ochs K., Hansen C., et al. Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab 81 8 (1996) 3045-3050
20. Davies T.F. Seeing T cells behind the eye. Eur J Endo-crinol 132 3 (1995) 264-265
21. Smith T.J. Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy. Thyroid 12 3 (2002) 197-203
22. Lu R., Wang P., Wartofsky L., et al. Oxygen free radicals in interleukin-1beta-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients. Thyroid 9 3 (1999) 297-303
23. Smith T.J., Koumas L., Gagnon A., et al. Orbital fibro-blast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 87 1 (2002) 385-392
24. Bartalena L., Pinchera A., and Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 21 2 (2000) 168-199
25. Gerding M.N., Terwee C.B., Dekker F.W., et al. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 7 6 (1997) 885-889
26. Kahaly G.J., Hardt J., Petrak F., et al. Psychosocial factors in subjects with thyroid-associated ophthalmopathy. Thyroid 12 3 (2002) 237-239
27. Perros P., Crombie A.L., and Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 42 1 (1995) 45-50
28. Glinoer D., Hesch D., Lagasse R., et al. The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey. Acta Endocrinol Suppl (Copenh) 285 (1987) 3-23
29. Cooper D.S. Antithyroid drugs. N Engl J Med 352 9 (2005) 905-917
30. Solomon B., Glinoer D., Lagasse R., et al. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 70 6 (1990) 1518-1524
31. Hertz S., and Radioactive iodine in the study of thyroid physiology V. The use of radioactive iodine therapy in hyperthyroidism. J Am Med Assoc 131 81 (1946)
32. Gaujoux S., Leenhardt L., Tresallet C., et al. Extensive thyroidectomy in Graves' disease. J Am Coll Surg 202 6 (2006) 868-873
33. Weetman A.P. Controversy in thyroid disease. J R Coll Physicians Lond 34 4 (2000) 374-380
34. Torring O., Tallstedt L., Wallin G., et al., Thyroid Study Group. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine-a prospective, randomized study. J Clin Endocrinol Metab 81 8 (1996) 2986-2993
35. Marcocci C., Bartalena L., Bogazzi F., et al. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism. Thyroid 2 2 (1992) 171-178
36. Weetman A.P., and Wiersinga W.M. Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey. Clin Endocrinol (Oxf) 49 1 (1998) 21-28
37. Bartalena L., Marcocci C., Bogazzi F., et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338 2 (1998) 73-78
38. Kung A.W., Yau C.C., and Cheng A. The incidence of ophthal-mopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methi-mazole. J Clin Endocrinol Metab 79 2 (1994) 542-546
39. Vestergaard H., and Laurberg P. Radioiodine and aggravation of Graves' ophthalmopathy. Lancet 2 8653 (1989) 47
40. Bartalena L., Marcocci C., Bogazzi F., et al. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321 20 (1989) 1349-1352
41. Perzik SL, Catz B. The place of total thyroidectomy in the management of thyroid disease. Surgery 196; 62(3): 436-40
42. Perzik S. The place of total thyroidectomy in the management of 909 patients with thyroid disease. Am J Surg 132 4 (1976) 480-483
43. Palit T.K., Miller C.C., and Miltenburg D.M. The efficacy of thyroidectomy for Graves' disease: A meta-analysis. J Surg Res 90 2 (2000) 161-165
44. Weber K.J., Solorzano C.C., Lee J.K., et al. Thyroidectomy remains an effective treatment option for Graves' disease. Am J Surg 191 3 (2006) 400-405
45. Barakate M.S., Agarwal G., Reeve T.S., et al. Total thyroidectomy is now the preferred option for the surgical management of Graves' disease. ANZ J Surg 72 5 (2002) 321-324
46. Ku C.F., Lo C.Y., Chan W.F., et al. Total thyroidectomy replaces subtotal thyroidectomy as the preferred surgical treatment for Graves' disease. ANZ J Surg 75 7 (2005) 528-531
47. Lal G., Ituarte P., Kebebew E., et al. Should total thyroid-ectomy become the preferred procedure for surgical management of Graves' disease?. Thyroid 15 6 (2005) 569-574
48. Koyuncu A., Dokmetas H.S., Turan M., et al. Comparison of different thyroidectomy techniques for benign thyroid disease. Endocr J 50 6 (2003) 723-727
49. Sosa J.A., Bowman H.M., Tielsch J.M., et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228 3 (1998) 320-330
50. Thomusch O, Machens A, Sekulla C et al. The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery 200; 133(2): 180-85
51. Kasuga Y., Sugenoya A., Kobayashi S., et al. Clinical evaluation of the response to surgical treatment of Graves' disease. Surg Gynecol Obstet 170 4 (1990) 327-330
52. Sugino K., Mimura T., Toshima K., et al. Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction. J Endocrinol Invest 16 3 (1993) 195-199
53. Winsa B., Rastad J., Akerstrom G., et al. Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy. Eur J Endocrinol 132 4 (1995) 406-412
54. Davis L.E., Lucas M.J., Hankins G.D., et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160 1 (1989) 63-70
55. Casey B.M., Dashe J.S., Wells C.E., et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105 2 (2005) 239-245
56. Catz B., and Perzik S.L. Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease. Am J Surg 118 3 (1969) 434-439
57. Frilling A., Goretzki P.E., Grussendorf M., et al. The influence of surgery on endocrine ophthalmopathy. World J Surg 14 3 (1990) 442-445 discussion
58. Frilling A., Goretzki P.E., Grussendorf M., et al. The influence of surgery on endocrine ophthalmopathy. World J Surg 14 3 (1990) 5-6
59. Fernandez Sanchez J.R., Rosell Pradas J., Carazo Martinez O., et al. Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy. Br J Surg 80 9 (1993) 1134-1136
60. Witte J., Goretzki P.E., Dotzenrath C., et al. Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial. World J Surg 24 11 (2000) 1303-1311
61. Werner S.C. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44 1 (1977) 203-204
62. Jarhult J., Rudberg C., Larsson E., et al. Graves' disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection. Thyroid 15 10 (2005) 1157-1164
63. Maurer E., Danila R., Dominguez E., Osei-Agymang T., et al. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy?. Chirurgia (Bucur) 103 3 (2008)
64. Kurihara H. Total thyroidectomy for the treatment of hyperthyroidism in patients with ophthalmopathy. Thyroid 12 3 (2002) 265-267
65. Menconi F., Marino M., Pinchera A., et al. Effects of total thyroid ablation versus near-total thyroidec-tomy alone on mild to moderate Graves' orbitopa-thy treated with intravenous glucocorticoids. J Clin Endocrinol Metab 92 5 (2007) 1653-1658
66. Abe Y., Sato H., Noguchi M., et al. Effect of subtotal thyroidectomy on natural history of ophthalmopathy in Graves' disease. World J Surg 22 7 (1998) 714-717
67. Mourits M.P., Lombardo S.H., van der Sluijs F.A., et al. Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves' patients. An exploratory study. Orbit 23 3 (2004) 161-168
68. Mourits M.P., Prummel M.F., Wiersinga W.M., et al. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 47 1 (1997) 9-14
69. Utech C.I., Khatibnia U., Winter P.F., et al. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy. Thyroid 5 3 (1995) 185-193
70. Prummel M.F., Suttorp-Schulten M.S., Wiersinga W.M., et al. A new ultrasonographic method to detect disease activity and predict response to immuno-suppressive treatment in Graves ophthalmopathy. Ophthalmology 100 4 (1993) 556-561
71. Gerding M.N., van der Zant F.M., van Royen E.A., et al. Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathy. Clin Endocrinol (Oxf) 50 3 (1999) 373-379
72. Wiersinga W.M., Gerding M.N., Prummel M.F., et al. Octreotide scintigraphy in thyroidal and orbital Graves' disease. Thyroid 8 5 (1998) 433-436
73. Edwards D.T., Bartley G.B., Hodge D.O., et al. Eyelid position measurement in Graves' ophthalmopathy: reliability of a photographic technique and comparison with a clinical technique. Ophthalmology 111 5 (2004) 1029-1034
74. Eckstein A.K., Plicht M., Lax H., et al. TSH-receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab (2006 Jul 11)
75. Miccoli P., Vitti P., Rago T., et al. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?. Surgery 120 6 (1996) 1020-1024 discussion
76. Miccoli P., Vitti P., Rago T., et al. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?. Surgery 120 6 (1996) 4-5
77. Agarwal A., and Mishra S.K. Role of surgery in the management of Graves' disease. Journal of the Indian Medical Association 99 5 (2001) 252
78. Agarwal A., and Mishra S.K. Role of surgery in the management of Graves' disease. Journal of the Indian Medical Association 99 5 (2001) 4-6
79. Nart A., Uslu A., Aykas A., et al. Total thyroidectomy for the treatment of recurrent graves' disease with ophthalmopathy. Asian Journal of Surgery/Asian Surgical Association 31 3 (2008) 115-118